Trials / Completed
CompletedNCT00263354
Oxaliplatin in Gastric Cancer
Oxaliplatin Phase II Trial in Association With 5FU and Folinic Acid in the Treatment of Advanced Unresectable or Metastatic Gastric Cancer.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the objective response to oxaliplatin/5FU/leucovorin combination chemotherapy in patients with advanced unresectable or metastatic gastric cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxaliplatin |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2006-07-01
- Completion
- 2006-07-01
- First posted
- 2005-12-08
- Last updated
- 2010-11-09
Source: ClinicalTrials.gov record NCT00263354. Inclusion in this directory is not an endorsement.